Terms: = Skin cancer AND SMAD2, MADH2, 4087, ENSG00000175387, MGC34440, MGC22139, hMAD-2, MADR2, JV18-1, hSMAD2, JV18 AND Treatment
18 results:
1. Modulating pancreatic cancer microenvironment: The efficacy of Huachansu in mouse models via TGF-β/Smad pathway.
Wang Y; Zhang A; Li Q; Liu C
J Ethnopharmacol; 2024 May; 326():117872. PubMed ID: 38325667
[TBL] [Abstract] [Full Text] [Related]
2. The effects of patchouli alcohol and combination with cisplatin on proliferation, apoptosis and migration in B16F10 melanoma cells.
Chang KF; Lai HC; Lee SC; Huang XF; Huang YC; Chou TE; Hsiao CY; Tsai NM
J Cell Mol Med; 2023 May; 27(10):1423-1435. PubMed ID: 37038620
[TBL] [Abstract] [Full Text] [Related]
3. MED1 Downregulation Contributes to TGFβ-Induced Metastasis by Inhibiting smad2 Ubiquitination Degradation in Cutaneous Melanoma.
Li Y; Wu J; Tian Y; Zhu Q; Ge Y; Yu H; Huang J; Li H; Zhang J; Zhang L; Hu L
J Invest Dermatol; 2022 Aug; 142(8):2228-2237.e4. PubMed ID: 35131256
[TBL] [Abstract] [Full Text] [Related]
4. TGFβ Signaling in Photoaging and UV-Induced skin cancer.
Ke Y; Wang XJ
J Invest Dermatol; 2021 Apr; 141(4S):1104-1110. PubMed ID: 33358021
[TBL] [Abstract] [Full Text] [Related]
5. Human osteoarthritis cartilage-derived stromal cells activate joint degeneration through TGF-beta lateral signaling.
Liu W; Feng M; Jayasuriya CT; Peng H; Zhang L; Guan Y; Froehlich JA; Terek RM; Chen Q
FASEB J; 2020 Dec; 34(12):16552-16566. PubMed ID: 33118211
[TBL] [Abstract] [Full Text] [Related]
6. Integrin α3β1 Is a Key Regulator of Several Protumorigenic Pathways during skin Carcinogenesis.
Ramovs V; Krotenberg Garcia A; Kreft M; Sonnenberg A
J Invest Dermatol; 2021 Apr; 141(4):732-741.e6. PubMed ID: 32805217
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-92 Expression in CD133
Shidal C; Singh NP; Nagarkatti P; Nagarkatti M
Cancer Res; 2019 Jul; 79(14):3622-3635. PubMed ID: 31015227
[TBL] [Abstract] [Full Text] [Related]
8. Differential expression of secreted factors SOSTDC1 and ADAMTS8 cause profibrotic changes in linear morphoea fibroblasts.
Badshah II; Brown S; Weibel L; Rose A; Way B; Sebire N; Inman G; Harper J; O'Shaughnessy RFL
Br J Dermatol; 2019 May; 180(5):1135-1149. PubMed ID: 30367460
[TBL] [Abstract] [Full Text] [Related]
9. Multikinase inhibitor sorafenib induces skin toxicities in tumor-bearing mice.
Tian A; Lu H; Zhang J; Fu S; Jiang Z; Lam W; Guan F; Chen L; Feng L; Cheng Y
Cancer Chemother Pharmacol; 2018 Jun; 81(6):1025-1033. PubMed ID: 29633006
[TBL] [Abstract] [Full Text] [Related]
10. Effects of a novel Nodal-targeting monoclonal antibody in melanoma.
Strizzi L; Sandomenico A; Margaryan NV; Focà A; Sanguigno L; Bodenstine TM; Chandler GS; Reed DW; Gilgur A; Seftor EA; Seftor RE; Khalkhali-Ellis Z; Leonardi A; Ruvo M; Hendrix MJ
Oncotarget; 2015 Oct; 6(33):34071-86. PubMed ID: 26460952
[TBL] [Abstract] [Full Text] [Related]
11. Endothelial-mesenchymal transition of brain endothelial cells: possible role during metastatic extravasation.
Krizbai IA; Gasparics Á; Nagyőszi P; Fazakas C; Molnár J; Wilhelm I; Bencs R; Rosivall L; Sebe A
PLoS One; 2015; 10(3):e0123845. PubMed ID: 25822751
[TBL] [Abstract] [Full Text] [Related]
12. CSMD1 exhibits antitumor activity in A375 melanoma cells through activation of the Smad pathway.
Tang MR; Wang YX; Guo S; Han SY; Wang D
Apoptosis; 2012 Sep; 17(9):927-37. PubMed ID: 22538441
[TBL] [Abstract] [Full Text] [Related]
13. Constitutive Smad linker phosphorylation in melanoma: a mechanism of resistance to transforming growth factor-β-mediated growth inhibition.
Cohen-Solal KA; Merrigan KT; Chan JL; Goydos JS; Chen W; Foran DJ; Liu F; Lasfar A; Reiss M
Pigment Cell Melanoma Res; 2011 Jun; 24(3):512-24. PubMed ID: 21477078
[TBL] [Abstract] [Full Text] [Related]
14. Elevated cutaneous Smad activation associates with enhanced skin tumor susceptibility in organ transplant recipients.
Harradine KA; Ridd K; Saunier EF; Clermont FF; Perez-Losada J; Moore DH; Epstein EH; Bastian BC; Akhurst RJ
Clin Cancer Res; 2009 Aug; 15(16):5101-7. PubMed ID: 19671862
[TBL] [Abstract] [Full Text] [Related]
15. Activation of Smad signaling enhances collagenase-3 (MMP-13) expression and invasion of head and neck squamous carcinoma cells.
Leivonen SK; Ala-Aho R; Koli K; Grénman R; Peltonen J; Kähäri VM
Oncogene; 2006 Apr; 25(18):2588-600. PubMed ID: 16407850
[TBL] [Abstract] [Full Text] [Related]
16. Global analysis of smad2/3-dependent TGF-beta signaling in living mice reveals prominent tissue-specific responses to injury.
Lin AH; Luo J; Mondshein LH; ten Dijke P; Vivien D; Contag CH; Wyss-Coray T
J Immunol; 2005 Jul; 175(1):547-54. PubMed ID: 15972691
[TBL] [Abstract] [Full Text] [Related]
17. Induction of an epithelial to mesenchymal transition in human immortal and malignant keratinocytes by TGF-beta1 involves MAPK, Smad and AP-1 signalling pathways.
Davies M; Robinson M; Smith E; Huntley S; Prime S; Paterson I
J Cell Biochem; 2005 Aug; 95(5):918-31. PubMed ID: 15861394
[TBL] [Abstract] [Full Text] [Related]
18. FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes.
von Willebrand M; Köhler K; Alanko T; Laiho M; Saksela O
Exp Dermatol; 2005 Mar; 14(3):202-8. PubMed ID: 15740593
[TBL] [Abstract] [Full Text] [Related]
